« Return to News | CROs/Service Providers

PPD Plans for Single-Digit Growth

Wednesday, January 20, 2010 09:57 AM

PPD expects limited revenue growth in 2010, according to the contract research organization’s (CRO’s) 2010 guidance announced last night.

The company anticipates net revenue for the full year 2010 to be in the range of $1.31billion to $1.43 billion with earnings per share (EPS) to be in the range of $1.00 to $1.12. PPD has not yet released its final year-end results for 2009, but, as of the end of the third quarter, PPD’s expected revenue for 2009 was $1.29 billion to $1.315 billion with EPS in the range of $1.38 to $1.40. The drop in EPS in 2010 is a result of PPD’s plans to spin off its compound partnering business from CRO operations. Once the spin-off is complete—by mid-year, PPD said—the two businesses will operate as two independent public companies. Only the CRO business will carry the PPD name.

"We have entered 2010 with clear objectives to restore growth in our business and to create long-term value for our shareholders," said PPD CEO David Grange in a statement. "Strengthening our business models, establishing innovative partnerships, and enhancing our global capacity remain key priorities for us in 2010. As we continue to align our business for success, we will continue to invest strategically in our global future. "

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.